Peter Wan retweetledi

Delighted to share our new manuscript published this week in @JITC showcasing a novel oncolytic herpes simplex virus armed to express a Bi-specific T cell Engager which targets NKG2D ligands in glioblastoma.
@Oncolytics_oxon
@OxfordOncology
@BRUKresearch
Journal for ImmunoTherapy of Cancer@jitcancer
New #JITC article: Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells bit.ly/4aguLrN @RichardBaugh3 @wktpeter
English





